Read time: 3 minutes. One of LUNGevity’s two flagship survivorship events, the International Lung Cancer Survivorship Conference (ILCSC), is being held virtually September 20 – 21
Read time: 1 minute On June 13, 2024, the US Food and Drug Administration (FDA) announced the accelerated approval of repotrectinib (Augtyro™) to treat patients with advanced NTRK
Read time: 8 minutes Thousands of oncologists, scientists, biotech and pharmaceutical representatives, patients, and advocates (including LUNGevity staff) met to discuss lifesaving
Read time: 3 minutes It’s been nearly a decade since Frank Sierawski was diagnosed with stage IV lung cancer in his 30s. The Sierawski family—including Frank, his wife Kathryn, and
Read time: 3 minutes It’s been nearly a decade since Frank Sierawski was diagnosed with stage IV lung cancer in his 30s. The Sierawski family—including Frank, his wife Kathryn, and